<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">1392220</PMID>
      <DateCompleted>
        <Year>1992</Year>
        <Month>11</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">1170-229X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>2</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>1992</Year>
              <Season>Sep-Oct</Season>
            </PubDate>
          </JournalIssue>
          <Title>Drugs &amp; aging</Title>
          <ISOAbbreviation>Drugs Aging</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in older patients.</ArticleTitle>
        <Pagination>
          <StartPage>374</StartPage>
          <EndPage>388</EndPage>
          <MedlinePgn>374-88</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Felodipine is a dihydropyridine calcium antagonist which may be administered once daily in an extended release (ER) formulation. As monotherapy in older patients with mild to moderate essential hypertension, felodipine ER once daily provides effective control of blood pressure (BP). The drug has also been effective, either as monotherapy or in combination with other antihypertensive medications, in comparisons with other antihypertensive agents, and does not adversely affect lipid profiles or, in patients with diabetes mellitus, glycaemic control. Results in patients with angina pectoris and congestive heart failure indicate a potential role for felodipine ER in these indications and data also suggest the drug reduces left ventricular hypertrophy. In addition, felodipine ER appears suitable for use in patients with concomitant respiratory disease, renal or hepatic dysfunction, cerebrovascular or peripheral ischaemic disease, or gout, making it particularly useful in the elderly who often have more than one significant clinical condition. Felodipine ER has generally been well tolerated by older patients in clinical trials, although further confirmation in the long term is desirable. Thus, felodipine ER effectively lowers BP in older patients with essential hypertension with the added convenience of once daily administration. It may be used as monotherapy or in combination with other antihypertensive agents and is a practical advance in the treatment of hypertension in the elderly.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Faulds</LastName>
            <ForeName>D</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Adis International Limited, Auckland, New Zealand.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sorkin</LastName>
            <ForeName>E M</ForeName>
            <Initials>EM</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>New Zealand</Country>
        <MedlineTA>Drugs Aging</MedlineTA>
        <NlmUniqueID>9102074</NlmUniqueID>
        <ISSNLinking>1170-229X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003692">Delayed-Action Preparations</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>OL961R6O2C</RegistryNumber>
          <NameOfSubstance UI="D015736">Felodipine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003692" MajorTopicYN="N">Delayed-Action Preparations</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015736" MajorTopicYN="N">Felodipine</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>83</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1992</Year>
          <Month>9</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1992</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1992</Year>
          <Month>9</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">1392220</ArticleId>
        <ArticleId IdType="doi">10.2165/00002512-199202050-00002</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>J Diabet Complications. 1990 Oct-Dec;4(4):170-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2151229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1989;36(5):481-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2753066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1991 Jul-Aug;1(4):289-302</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1794021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>JAMA. 1991 Jun 26;265(24):3255-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2046107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DICP. 1991 Sep;25(9):1007-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1949959</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990 Mar;15(3):347-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1691355</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1992 Aug;44(2):251-77</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1382018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardiovasc Drugs Ther. 1990 Dec;4(6):1495-500</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2081141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1990 Sep;30(3):481-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2145957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990;15 Suppl 4:S108-10</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1693714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stroke. 1984 Jul-Aug;15(4):635-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6611613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardiovasc Drugs Ther. 1990 Feb;4(1):253-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2285618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1991 May;1(3):163-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1794013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabet Med. 1989 Dec;6(9):809-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2533042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1986;30(2):133-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3519241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hum Hypertens. 1990 Dec;4(6):703-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2151392</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hypertens. 1988 Mar;6(3):231-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3361121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1991;18 Suppl 10:S36-41</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1725001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1991;41(1):73-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1782982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990 Mar;15(3):428-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1691367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Intern Med. 1992 Mar;231(3):303-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1532616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabet Med. 1988 Apr;5(3):261-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2967148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am Rev Respir Dis. 1988 Jul;138(1):54-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3202400</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1987;34 Suppl 3:151-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3443059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1992 Feb 15;304(6824):412-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1347711</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1990;38(6):529-33</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2373126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1991 Jan;1(1):36-47</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1794003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 1988;64 Suppl 3:76-83; discussion 90-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3074301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1991 Nov-Dec;1(6):467-76</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1794033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1990;39(6):539-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2095339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990;15 Suppl 4:S100-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1693710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Hypertens. 1992 Apr;5(4 Pt 1):238-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1599636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Intern Med. 1991 Mar;229(3):233-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2007841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1991;41(5):393-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1684748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1992;42(1):25-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1541312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1992 Feb 15;304(6824):405-12</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1445513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1992 Jan-Feb;2(1):1-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1554969</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1987;10 Suppl 1:S177-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2442513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1243-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2434753</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacokinet. 1991 Dec;21(6):418-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1782737</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Cardiol. 1991 Aug 15;68(5):457-62</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1872271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Cardiol. 1992 Mar 1;69(6):639-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1531566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hypertension. 1983 Jul-Aug;5(4 Pt 2):II97-102</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6345378</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Intern Med. 1989 Apr;225(4):237-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2656902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1985 Oct;20(4):383-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4074606</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fortschr Med. 1991 Jan 30;109(3):53-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1902814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Intern Med. 1990 Dec;228(6):597-602</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2280237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990;15 Suppl 4:S95-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1693740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Postgrad Med J. 1985 Jul;61(717):563-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2862625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Cardiol. 1991 Dec 15;68(17):1587-92</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1746458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1988 Oct;36(4):387-428</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3069435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 1991 Nov 23;338(8778):1281-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1682683</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Diabet Med. 1986 Jul-Aug;3(4):301-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2949915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hum Hypertens. 1991 Feb;5(1):49-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2041036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1989;37(2):191-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2676559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Hum Hypertens. 1989 Dec;3(6):467-70</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2607521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1991 May;1(3):194-211</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1686570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs Aging. 1992 Jul-Aug;2(4):262-86</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1504442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1989;37(5):459-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2598984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Am J Hypertens. 1990 Aug;3(8 Pt 1):611-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2222952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1991;40(3):313-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2060571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Pharmacol. 1990 Nov;30(11):1020-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2243149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Med J (Clin Res Ed). 1984 Dec 1;289(6457):1495-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6150745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BMJ. 1989 Apr 29;298(6681):1147-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2500168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1989;14 Suppl 10:S7-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2483573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kidney Int Suppl. 1992 May;36:S54-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1614069</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
